Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Ann Marie Egloff, Ph.D.

Concepts (341)

Concepts are derived automatically from a person's publications.
The timeline below shows the dates (blue tick marks) of publications associated with Ann Marie Egloff's top concepts. The average publication date for each concept is shown as a red circle, illustrating changes in the primary topics that Ann Marie Egloff has written about over time.
Cyclin B, 2 publications between 2005 and 2006, average publication date December 2005. Receptor Cross-Talk, 1 publications between 2009 and 2009, average publication date October 2009. Proto-Oncogene Proteins pp60(c-src), 2 publications between 2008 and 2011, average publication date January 2010. STAT3 Transcription Factor, 3 publications between 2009 and 2011, average publication date February 2010. Small Cell Lung Carcinoma, 1 publications between 2012 and 2012, average publication date February 2012. Receptors, Bombesin, 2 publications between 2012 and 2012, average publication date February 2012. Mouth Mucosa, 1 publications between 2012 and 2012, average publication date March 2012. Ear Canal, 1 publications between 2012 and 2012, average publication date March 2012. Carcinoma, Squamous Cell, 30 publications between 2006 and 2022, average publication date January 2013. Antineoplastic Combined Chemotherapy Protocols, 6 publications between 2008 and 2021, average publication date February 2014. Molecular Targeted Therapy, 4 publications between 2011 and 2018, average publication date May 2014. Head and Neck Neoplasms, 36 publications between 2006 and 2022, average publication date October 2014. Mouth Neoplasms, 4 publications between 2008 and 2022, average publication date November 2015.

To see the data from this visualization as text, click here.
Egloff's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (341)
Explore
_
Co-Authors (41)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.